CD36, a Class B Scavenger Receptor, Is Expressed on Microglia in Alzheimer's Disease Brains and Can Mediate Production of Reactive Oxygen Species in Response to β-Amyloid Fibrils

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324

Activation of microglial cells by β-amyloid protein and interferon-γ

Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314

CD36 is a receptor for oxidized low density lipoprotein

Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., & Protter, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50272-1 · Cited by 1,282

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection

Suzuki, H. I., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., et al. (1997) · Nature · doi:10.1038/386292a0 · Cited by 1,226

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,037

Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils

Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727

β-Amyloid-mediated vasoactivity and vascular endothelial damage

Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703

Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system.

Sedgwick, J. D., Schwender, S., Imrich, H., Dörries, R., Butcher, G. W., & ter Meulen, V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7438 · Cited by 691

Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1.

Bornstein, P. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.3.503 · Cited by 666

Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor

Paresce, D. M., Ghosh, R. N., & Maxfield, F. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80187-7 · Cited by 663

Metabolic Control of Smoldering Neuroinflammation

Peruzzotti‐Jametti, L., Willis, C. M., Hamel, R., Krzak, G., & Pluchino, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705920 · Cited by 37

Cerebral amyloid angiopathy impact on endothelium

Grinberg, L. T., Korczyn, A. D., & Heinsen, H. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.08.005 · Cited by 42

Menopausal transition: A possible risk factor for brain pathologic events

Bonomo, S., Rigamonti, A. E., Giunta, M., Galimberti, D., Guaita, A., Gagliano, M. G., Müller, E. E., & Cella, S. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.017 · Cited by 39

Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer’s disease

Madadi, S., Schwarzenbach, H., Saidijam, M., Mahjub, R., & Soleimani, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0354-3 · Cited by 41

T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy

Lustig, G., Cele, S., Karim, F., Derache, A., Ngoepe, A., Khan, K., Gosnell, B. I., Moosa, M. S., Ntshuba, N., Marais, S., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009871 · Cited by 36

Nogo receptor impairs the clearance of fibril amyloid‐β by microglia and accelerates Alzheimer’s‐like disease progression

Wang, J., Qin, X., Sun, H., He, M., Lv, Q., Gao, C., He, X., & Liao, H. (2021) · Aging Cell · doi:10.1111/acel.13515 · Cited by 37

Reduced axon sprouting after treatment that diminishes microglia accumulation at lesions in the leech CNS

Ngu, E. M., Sahley, C. L., & Muller, K. J. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21386 · Cited by 40

A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis

Xue, D., Zhao, M., Wang, Y., Wang, L., Yang, Y., Wang, S., Zhang, R., Zhao, Y., & Liu, R. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.013 · Cited by 39

Prostaglandin E2 Receptor Subtype 2 Regulation of Scavenger Receptor CD36 Modulates Microglial Aβ42 Phagocytosis

Li, X., Melief, E. J., Postupna, N. O., Montine, K. S., Keene, C. D., & Montine, T. J. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.09.016 · Cited by 37

Amniotic Mesenchymal Stem Cells Decrease Aβ Deposition and Improve Memory in APP/PS1 Transgenic Mice

Zheng, X., Wan, Q.-Q., Zheng, C.-Y., Zhou, H., Dong, X., Deng, Q., Yao, H., Fu, Q., Gao, M., Yan, Z., et al. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2226-8 · Cited by 37

Peripheral serum metabolomic profiles inform central cognitive impairment

Wang, J., Wei, R., Xie, G., Arnold, M., Kueider‐Paisley, A., Louie, G., Dehkordi, S. M., Blach, C., Baillie, R., Han, X., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70703-w · Cited by 38

Potential Immunotargets for Alzheimer's Disease Treatment Strategies

Fernández, P. L., Britton, G. B., & Rao, K. S. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121222 · Cited by 38

Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model

Wang, Q., Xu, Y., Chen, J., Qin, Y., Liu, M., Liu, Y., Xie, M.-J., Yu, Z., Zhu, Z., & Wang, W. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.011 · Cited by 39

Chronic cerebral hypoperfusion alters amyloid-β peptide pools leading to cerebral amyloid angiopathy, microinfarcts and haemorrhages in Tg-SwDI mice

Salvadores, N., Searcy, J. L., Holland, P. R., & Horsburgh, K. J. (2017) · Clinical Science · doi:10.1042/cs20170962 · Cited by 37

α1 integrin activation: A link between β‐amyloid deposition and neuronal death in aging hippocampal neurons

Anderson, K. L., & Ferreira, A. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20018 · Cited by 37

Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer’s disease

Manral, A., Saini, V., Meena, P., & Tiwari, M. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.08.024 · Cited by 36

ERK1/2 and p38 MAP kinases control prion protein fragment 90–231‐induced astrocyte proliferation and microglia activation

Thellung, S., Villa, V., Corsaro, A., Pellistri, F., Venezia, V., Russo, C., Aceto, A., Robello, M., & Florio, T. (2007) · Glia · doi:10.1002/glia.20559 · Cited by 38

CD36 expression and brain function: does CD36 deficiency impact learning ability?

Abumrad, N. A., Ajmal, M., Pothakos, K., & Robinson, J. K. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.09.012 · Cited by 37

Microglia in Alzheimer's Disease: A Role for Ion Channels

Thei, L., Imm, J. L., Kaisis, E., Dallas, M. L., & Kerrigan, T. L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00676 · Cited by 37

Microglia in the Human Nervous System during Development

Rezaie, P. (2003) · Neuroembryology and Aging · doi:10.1159/000068498 · Cited by 38

The adhesion and migration of microglia to β-amyloid (Aβ) is decreased with aging and inhibited by Nogo/NgR pathway

Fang, Y., Wang, J., Yao, L., Li, C., Wang, J., Liu, Y., Tao, X., Sun, H., & Liao, H. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1250-1 · Cited by 35

CD36 Participates in PrP106–126-Induced Activation of Microglia

Kouadir, M., Yang, L., Tan, R., Shi, F., Lu, Y., Zhang, S., Yin, X., Zhou, X., & Zhao, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030756 · Cited by 34

Extracellular Vesicles of Mesenchymal Stromal Cells Can be Taken Up by Microglial Cells and Partially Prevent the Stimulation Induced by β-amyloid

Kaniowska, D., Wenk, K., Rademacher, P., Weiss, R., Fabian, C., Schulz, I., Guthardt, M., Lange, F., Greiser, S., Schmidt, M., et al. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10261-4 · Cited by 35

Expression Pattern of Scavenger Receptors and Amyloid-β Phagocytosis of Astrocytes and Microglia in Culture are Modified by Acidosis: Implications for Alzheimer’s Disease

Eugenín, J. L., Vecchiola, A., Murgas, P., Arroyo, P., Cornejo, F., & Rommy von Bernhardi, M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160083 · Cited by 35

New insights in drug development for Alzheimer's disease based on microglia function

Qiao, O., Ji, H., Zhang, Y., Zhang, X., Zhang, X., Liu, N., Huang, L., Liu, C., & Gao, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111703 · Cited by 35

Review of Amyotrophic Lateral Sclerosis, Parkinson’s and Alzheimer’s diseases helps further define pathology of the novel paradigm for Alzheimer’s with heavy metals as primary disease cause

Cavaleri, F. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.10.009 · Cited by 36

Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology

Gebril, H. M., Aryasomayajula, A., de Lima, M. R. N., Uhrich, K. E., & Moghe, P. V. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-023-00393-7 · Cited by 37

Linking Alzheimer’s Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation

Kamal, M. A., Priyamvada, S., Anbazhagan, A. N., Jabir, N. R., Tabrez, S. S. M., & Greig, N. H. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660137 · Cited by 37

Europium-Doped Cerium Oxide Nanoparticles for Microglial Amyloid Beta Clearance and Homeostasis

Machhi, J., Yeapuri, P., Marković, M., Patel, M., Yan, W., Lu, Y., Cohen, J. D., Hasan, M., Abdelmoaty, M. M., Zhou, Y., et al. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00847 · Cited by 36

Proteomic identification of a novel protein regulated in CA1 and CA3 hippocampal regions during intermittent hypoxia

Klein, J. B., Gozal, D., Pierce, W. M. J., Thongboonkerd, V., Scherzer, J. A., Sachleben, L. R., Guo, S., Cai, J., & Gozal, E. (2003) · Respiratory Physiology & Neurobiology · doi:10.1016/s1569-9048(03)00074-0 · Cited by 33

Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy

Ahn, E. H., & Park, J. (2025) · Cells · doi:10.3390/cells14020089 · Cited by 37

Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis

Salajegheh, M. K., Raju, R. P., Schmidt, J., & Dalakas, M. C. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.04.022 · Cited by 32

2,5-Hexanedione induces dopaminergic neurodegeneration through integrin αMβ2/NADPH oxidase axis-mediated microglial activation

Zhang, C., Hou, L., Yang, J., Che, Y., Sun, F., Li, H., & Wang, Q. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0091-7 · Cited by 32

Identification of synaptic plasma membrane proteins co‐precipitated with fibrillar β‐amyloid peptide

Verdier, Y., Huszár, E., Penke, B., Penke, Z., Woffendin, G., Ščigelová, M., Fülöp, L., Szűcs, M., Medzihradszky, K. F., & Janáky, T. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03158.x · Cited by 30

Role of LDL Cholesterol and Endolysosomes in Amyloidogenesis and Alzheimer’s Disease

Chen, X. (2014) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000236 · Cited by 31

DHA and vitamin E antagonized the Aβ 25–35 -mediated neuron oxidative damage through activation of Nrf2 signaling pathways and regulation of CD36, SRB1 and FABP5 expression in PC12 cells

Huang, X., Zhen, J., Dong, S., Zhang, H., Halm‐Lutterodt, N. V., & Yuan, L. (2019) · Food & Function · doi:10.1039/c8fo01713a · Cited by 28

Carotenoids and Neurobiological Health

Guest, J., & Grant, R. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_11 · Cited by 28

Amyloid‐β peptides induce cell proliferation and macrophage colony‐stimulating factor expression via the PI3‐kinase/Akt pathway in cultured Ra2 microglial cells

Ito, S., Sawada, M., Haneda, M., Fujii, S., Oh‐hashi, K., Kiuchi, K., Takahashi, M., & Isobe, K. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.048 · Cited by 28

The Role of CD36/GPIV in Platelet Biology

Bendas, G., & Schlesinger, M. (2023) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0043-1768935 · Cited by 27

Involvement of small GTPase RhoA in the regulation of superoxide production in BV2 cells in response to fibrillar Aβ peptides

Moon, M.-Y., Kim, H.-J., Li, Y., Kim, J.-G., Jeon, Y.-J., Won, H.-Y., Kim, J.-S., Kwon, H.-Y., Choi, I.-G., Ro, E., et al. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.023 · Cited by 27

Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity

Bennett, N. K., Chmielowski, R., Abdelhamid, D. S., Faig, J. J., Francis, N. L., Baum, J., Pang, Z. P., Uhrich, K. E., & Moghe, P. V. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.001 · Cited by 27

The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host’s Defense Strategy against Neuroinflammation

Bedoui, Y., Neal, J. W., & Gasque, P. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9793-6 · Cited by 28

Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds

Madsen, H. B., & Vilhardt, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010227 · Cited by 26

Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies

Dileep, K. V., & Chandra, R. (2019) · Current Drug Targets · doi:10.2174/1389450120666190806153206 · Cited by 26

Defects of Nutrient Signaling and Autophagy in Neurodegeneration

Ondaro, J., Hernández-Eguiazu, H., Garciandia-Arcelus, M., Loera‐Valencia, R., Rodríguez-Gómez, L., Jiménez-Zúñiga, A., Goikolea, J., Rodriguez‐Rodriguez, P., Ruiz‐Martínez, J., Moreno, F., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.836196 · Cited by 28

Role of Scavenger Receptors in Glia-Mediated Neuroinflammatory Response Associated with Alzheimer’s Disease

Cornejo, F., & Rommy von Bernhardi, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/895651 · Cited by 25

Immunometabolic modulation of retinal inflammation by CD36 ligand

Mellal, K., Omri, S., Mulumba, M., Tahiri, H., Fortin, C. F., Dorion, M., Pham, H., García‐Ramos, Y., Zhang, J., Pundir, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49472-8 · Cited by 28

The receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and exploiting common ground for novel amyloidosis therapies

Abedini, A., Derk, J., & Schmidt, A. M. (2018) · Protein Science · doi:10.1002/pro.3425 · Cited by 25

Protein aggregates stimulate macropinocytosis facilitating their propagation

Yerbury, J. J. (2016) · Prion · doi:10.1080/19336896.2016.1141860 · Cited by 26

High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease

Pedrini, S., Chatterjee, P., Hone, E., & Martins, R. N. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15170 · Cited by 22

Collagen inhibits phagocytosis of amyloid in vitro and in vivo and may act as a ‘don’t eat me’ signal

Jackson, J. W., Foster, J. S., Martin, E. B., Macy, S. D., Wooliver, C., Balachandran, M., Richey, T., Heidel, R. E., Williams, A. D., Kennel, S. J., et al. (2022) · Amyloid · doi:10.1080/13506129.2022.2155133 · Cited by 22

Scavenger receptor control of chromogranin A‐induced microglial stress and neurotoxic cascades

Hooper, C., Fry, V. A. H., Sevastou, I. G., & Pocock, J. M. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.09.049 · Cited by 24

Common aspects between glaucoma and brain neurodegeneration

Saccà, S. C., Paluan, F., Gandolfi, S., Manni, G., Cutolo, C. A., & Izzotti, A. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108323 · Cited by 25

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer’s Disease?

Lue, L., Andrade, C., Sabbagh, M. N., & Walker, D. G. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/918680 · Cited by 24

Lack of Association of CD36 SNPs With Early Onset Obesity: A Meta‐Analysis in 9,973 European Subjects

Choquet, H., Labrune, Y., Graeve, F. D., Hinney, A., Hebebrand, J., Scherag, A., Lecœur, C., Tauber, M., Balkau, B., Elliott, P., et al. (2010) · Obesity · doi:10.1038/oby.2010.226 · Cited by 24

Roles of glial cells in neuroinflammation and neurodegeneration

Takeuchi, H. (2013) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12059 · Cited by 27

Expression of Scavenger receptor A on antigen presenting cells is important for CD4+ T-cells proliferation in EAE mouse model

Levy‐Barazany, H., & Frenkel, D. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-120 · Cited by 23

Raft aggregation with specific receptor recruitment is required for microglial phagocytosis of Aβ42

Persaud‐Sawin, D., Banach, L., & Harry, G. J. (2008) · Glia · doi:10.1002/glia.20759 · Cited by 24

Microglia in Alzheimer’s Disease

Süß, P., & Schlachetzki, J. C. M. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200212155234 · Cited by 26

Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy

Klinkovskij, A., Shepelev, M. V., Isaakyan, Y. A., Aniskin, D., & Ulasov, I. V. (2023) · Biomedicines · doi:10.3390/biomedicines11123333 · Cited by 24

Deciphering metal-induced oxidative damages on glycated albumin structure and function

Baraka-Vidot, J., Navarra, G., Leone, M., Bourdon, E., Militello, V., & Rondeau, P. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.017 · Cited by 23

The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment

Giunta, M., Rigamonti, A. E., Scarpini, E. A., Galimberti, D., Bonomo, S., Venturelli, E., Müller, E. E., & Cella, S. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.002 · Cited by 23

Postmortem Adult Human Microglia Proliferate in Culture to High Passage and Maintain Their Response to Amyloid-β

Guo, L., Rezvanian, A., Kukreja, L., Hoveydai, R., Bigio, E. H., Mesulam, M. M., Khoury, J. B. E., & Geula, C. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160394 · Cited by 21

Design, synthesis, and biological evaluation of furosemide analogs as therapeutics for the proteopathy and immunopathy of Alzheimer's disease

Wang, Z., Wang, Y., Pasangulapati, J. P., Stover, K. R., Liu, X., Schier, S., & Weaver, D. F. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113565 · Cited by 22

Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration

Dar, K. B., Bhat, A. H., Amin, S., Reshi, B. A., Zargar, M. A., Masood, A., & Ganie, S. A. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00741-0 · Cited by 23

Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation

Takatori, S., Kondo, M., & Tomita, T. (2025) · Inflammation and Regeneration · doi:10.1186/s41232-025-00383-4 · Cited by 28

The expression of CD36 in vessels with blood–brain barrier impairment in a stroke‐prone hypertensive model

Ueno, M., Nakagawa, T., Nagai, Y., Nishi, N., Kusaka, T., Kanenishi, K., Onodera, M., Hosomi, N., Huang, C., Yokomise, H., et al. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01172.x · Cited by 22

The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease

Busch, L., Eggert, S., Endres, K., & Bufe, B. (2022) · Cells · doi:10.3390/cells11213421 · Cited by 20

Fundamental Neurochemistry Review: Lipids across microglial states

Traetta, M. E., Vecchiarelli, H. A., & Tremblay, M. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16259 · Cited by 21

Retinal ganglion cell loss and gliosis in the retinofugal projection following intravitreal exposure to amyloid-beta

Simons, E. S., Smith, M. A., Crish, S. D., & Crish, S. D. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105146 · Cited by 19

Neuronal growth regulator 1 promotes adipocyte lipid trafficking via interaction with CD36

Yoo, A., Joo, Y., Cheon, Y., Lee, S. J., & Lee, S. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100221 · Cited by 18

Identification of oxytocin expression in human and murine microglia

Maejima, Y., Yokota, S., Ono, T., Yu, Z., Yamachi, M., Hidema, S., Nollet, K. E., Nishimori, K., Tomita, H., Yaginuma, H., et al. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110600 · Cited by 20

Benefits of aged garlic extract on Alzheimer's disease: Possible mechanisms of action (Review)

Sripanidkulchai, B. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8390 · Cited by 19

Commentary on Myers et al.: Growing role of the innate immunity receptor CD36 in central nervous system diseases

García‐Bonilla, L., Park, L., & Iadecola, C. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.08.016 · Cited by 19

Behavioral characterization of CD36 knockout mice with SHIRPA primary screen

Zhang, S., Wang, W., Li, J., Cheng, K., Zhou, J., Zhu, D., Yang, D., Liang, Z., Fang, L., Liao, L., et al. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.11.027 · Cited by 19

Ccr2-64i and Ccr5 Δ32 Polymorphisms in Patients with Late-Onset Alzheimer's disease; A Study from Iran (Ccr2-64i And Ccr5 Δ32 Polymorphisms in Alzheimer's disease).

Khorshid, H. R. K., Manoochehri, M., Nasehi, L., Ohadi, M., Rahgozar, M., & Kamali, K. (2012) · Europe PMC (PubMed Central) · Cited by 19

Peroxisome Proliferator-Activated Receptor Gamma Enhances the Activity of an Insulin Degrading Enzyme-Like Metalloprotease for Amyloid-β

Espuny-Camacho, I., Dominguez, D. I., Merchiers, P., Rompaey, L. V., Selkoe, D. J., & Strooper, B. D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091633 · Cited by 18

Manipulation of microglial activity as a therapy for Alzheimer s disease

Ling, E. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s342 · Cited by 15

The expression of LDL receptor in vessels with blood–brain barrier impairment in a stroke-prone hypertensive model

Ueno, M., Wu, B., Nakagawa, T., Nagai, Y., Onodera, M., Huang, C., Kusaka, T., Kanenishi, K., & Sakamoto, H. (2010) · Histochemistry and Cell Biology · doi:10.1007/s00418-010-0705-y · Cited by 17

β-Amyloid (Aβ40, Aβ42) binding to modified LDL accelerates macrophage foam cell formation

Schulz, B., Liebisch, G., Grandl, M., Werner, T., Barlage, S., & Schmitz, G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.08.002 · Cited by 16

Elucidation of mechanism of blood-brain barrier damage for prevention and treatment of vascular dementia

Ueno, M. (2017) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001004 · Cited by 15

Repetitive Traumatic Brain Injury Causes Neuroinflammation before Tau Pathology in Adolescent P301S Mice

Izzy, S., Brown-Whalen, A., Yahya, T., Sarro-Schwartz, A., Jin, G., Chung, J. Y., Lüle, S., Morsett, L. M., Alquraini, A., Wu, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020907 · Cited by 16

Amyloid β-Induced Inflammarafts in Alzheimer’s Disease

Ding, S., Choi, S., & Miller, Y. I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104592 · Cited by 19

CD36‐Binding Amphiphilic Nanoparticles for Attenuation of α‐Synuclein‐Induced Microglial Activation

Zhao, N., Francis, N. L., Song, S., Kholodovych, V. V., Calvelli, H. R., Hoop, C. L., Pang, Z. P., Baum, J., Uhrich, K. E., & Moghe, P. V. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100120 · Cited by 15

Cellular response to β‐amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics

Zhang, H., Li, X., Wang, X., Xu, J., Elefant, F., & Wang, J. (2023) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12313 · Cited by 15

Comparison of mRNA Expression Patterns of Class B Scavenger Receptors in BV2 Microglia upon Exposure to Amyloidogenic Fragments of Beta-Amyloid and Prion Proteins

Kouadir, M., Yang, L., Tu, J., Yin, X., Zhou, X., & Zhao, D. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1234 · Cited by 14

Effective Targeting of Aβ to Macrophages by Sonochemically Prepared Surface-Modified Protein Microspheres

Richman, M., Perelman, A., Gertler, A. A., & Rahimipour, S. (2012) · Biomacromolecules · doi:10.1021/bm301401b · Cited by 15

β-adaptin: Key molecule for microglial scavenger receptor function under oxidative stress

Manzano-León, N., Delgado-Coello, B., Guaderrama-Díaz, M., & Mas-Oliva, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.077 · Cited by 14

The Emerging Role of PCSK9 in the Pathogenesis of Alzheimer’s Disease: A Possible Target for the Disease Treatment

Testa, G., Giannelli, S., Staurenghi, E., Cecci, R., Floro, L., Gamba, P., Sottero, B., & Leonarduzzi, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413637 · Cited by 14

Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1Δexon9 mouse models identifies shared features with human Alzheimer’s brain molecular pathology

Readhead, B., Haure‐Mirande, J., Zhang, B., Haroutunian, V. H., Gandy, S., Schadt, E. E., Dudley, J. T., & Ehrlich, M. E. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.167 · Cited by 15

The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer’s-related disease and preserving cognition

Danziger, R., Fuchs, D.-T., Koronyo, Y., Rentsendorj, A., Sheyn, J., Hayden, E. Y., Teplow, D. B., Black, K. L., Fuchs, S., Bernstein, K. E., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1179315 · Cited by 16

Mild TBI in the elderly – risk factor for rapid cognitive impairment in Alzheimer’s disease

Stovicek, P. O., Friedmann, C., Marinescu, D., Văduva, I. A., Bondari, S., Trifu, S. C., & Marinescu, I. P. (2020) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.1.07 · Cited by 14

S100A9 induces aggregation-prone conformation in Abeta peptides: a combined experimental and simulation study

Zhao, L. N., Zhang, T., Zhang, C., Wang, C., Morozova‐Roche, L. A., Chew, L. Y., & Mu, Y. (2013) · RSC Advances · doi:10.1039/c3ra43665a · Cited by 14

Microglial Dysfunction and Amyloid-Beta Pathology in Alzheimer’s Disease and HIV-Associated Neurocognitive Disorders

Njoku, G. C., & Kanmogne, G. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189069 · Cited by 15

Chronic IL-21 drives neuroinflammation and promotes lipid accumulation in microglia

Oyamada, H. A. A., Ying, Y., Agrawal, S., Liu, A., Subramanian, V. S., Bento, C. A. M., & Agrawal, A. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00510-2 · Cited by 14

CD36 Gene Polymorphisms Are Associated with Intracerebral Hemorrhage Susceptibility in a Han Chinese Population

Gong, Q., Liao, M., Liu, L., Xiong, X., Zhang, Q., Zhong, Q., Zhou, K., Yang, Y., Meng, Z., Gong, C., et al. (2017) · BioMed Research International · doi:10.1155/2017/5352071 · Cited by 13

Liver Growth Factor “LGF” as a Therapeutic Agent for Alzheimer’s Disease

Gonzalo‐Gobernado, R., Perucho, J., Vallejo-Muñoz, M., Casarejos, M. J., Reimers, D., Jiménez‐Escrig, A., Gómez, A., de Asanza, G. M. U., & Bazán, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239201 · Cited by 13

The role of NADPH oxidase (NOX) enzymes in neurodegenerative disease

Ajayi, A., Yu, X., & Ström, A. (2012) · Frontiers in Biology · doi:10.1007/s11515-012-1250-y · Cited by 12

Age, sex, and regional differences in scavenger receptor CD36 in the mouse brain: Potential relevance to cerebral amyloid angiopathy and Alzheimer's disease

Edler, M. K., Johnson, C. T., Ahmed, H. S., & Richardson, J. R. (2020) · The Journal of Comparative Neurology · doi:10.1002/cne.25089 · Cited by 14

CD36-mediated ROS/PI3K/AKT signaling pathway exacerbates cognitive impairment in APP/PS1 mice after noise exposure

Zhou, Z., Jiang, W., Wang, Y., Si, J., Zeng, X.-S., & Li, L. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.175879 · Cited by 13

CD36 Mediates the Innate Host Response to β-Amyloid

El Khoury, J. B., Moore, K. J., Means, T. K., Leung, J., Terada, K., Toft, M., Freeman, M. W., & Luster, A. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021546 · Cited by 483

Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils

Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727

The Journal of Experimental Medicine

Khoury, J. B. E., Moore, K. J., Means, T. K., Leung, J., Terada, K., Toft, M., Freeman, M. W., & Luster, A. D. (2013)

CD36 null mice reveal a key role for CD36 in β‐amyloid induced microglial activation

Khoury, J. B. E., Moore, K. J., Freeman, M. W., & Luster, A. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00064.x

CD36 overexpression in human brain correlates with β-amyloid deposition but not with Alzheimer's disease

Ricciarelli, R., d'Abramo, C., Zingg, J.-M., Giliberto, L., Markesbery, W., Azzi, A., Marinari, U. M., Pronzato, M. A., & Tabaton, M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.01.007 · Cited by 66